No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Encorafenib, Cetuximab, and mFOLFOX6 Improves Survival in BRAF-Mutated Colorectal Cancer

byAstrid BradshawandAlisha Yi

June 13, 2025

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Neoadjuvant chemotherapy does not improve disease-free survival in patients with locally advanced colon cancer

Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy

2MM: AI Roundup- Medtronic’s AI-Robotic Spine Platform, 90% Phase I Success for AI-Designed Drugs, and UCSD’s AI Cancer Risk Predictor [Feb 17th, 2026]

Use of psychiatric medications may be associated with a higher risk of amyotrophic lateral sclerosis

RelatedReports

Development of a risk index for colorectal cancer screening

Chronic Disease

Neoadjuvant chemotherapy does not improve disease-free survival in patients with locally advanced colon cancer

March 25, 2026

AI Roundup

Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy

February 20, 2026

AI Roundup

2MM: AI Roundup- Medtronic’s AI-Robotic Spine Platform, 90% Phase I Success for AI-Designed Drugs, and UCSD’s AI Cancer Risk Predictor [Feb 17th, 2026]

February 17, 2026

StudyGraphics

#VisualAbstract: 3-Year Structured Exercise after Adjuvant Chemotherapy Improved Survival for Colon Cancer

August 7, 2025

Colchicine may lower the risk of cardiovascular events in patients with coronary disease

Transcatheter closure of patent ductus arteriosus demonstrates similar outcomes compared to surgical repair

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

2 Minute Medicine Rewind June 16, 2025

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result